MichaelA.VogelbaumMDPh.D.

Brain & Spinal Tumor, Pituitary Surgery, Skull Base

Program Leader, NeuroOncology and Chief of Neurosurgery. Moffitt Cancer Center

Overview of Dr. Vogelbaum

Dr. Michael Vogelbaum is a neurosurgeon in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. He received his medical degree from University of Virginia School of Medicine and has been in practice 25 years. Dr. Vogelbaum accepts several types of health insurance, listed below. He is one of 20 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Neurosurgery. He has more than 100 publications and over 500 citings.

Office
12902 USF Magnolia Drive
Tampa, FL 33612
Book by Phone+1(763) 703-1509

Fax+1 813-745-3068

Education & Training

Washington University/B-JH/SLCH ConsortiumResidency, Neurological Surgery, 1993 - 1999
Washington University/B-JH/SLCH ConsortiumInternship, Transitional Year, 1992 - 1993
University of Virginia School of MedicineClass of 1992

Certifications & Licensure

FL State Medical License 2018 - 2027
MI State Medical License 2002 - 2025
MO State Medical License 1998 - 2025
OH State Medical License 1999 - 2025
NY State Medical License 2003 - 2020
CT State Medical License 2003 - 2019
PA State Medical License 2003 - 2014
IL State Medical License 2002 - 2005
American Board of Neurological Surgery Neurological Surgery
Join now to see all

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Fellow (FACS) American College of Surgeons
Fellow (FAANS) American Association of Neurological Surgeons
Join now to see all

Clinical Trials

Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas Start of enrollment: 2002 Jul 01
Completed
Phase 2
Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme Start of enrollment: 2002 Aug 01
Unknown status
Phase 2
A Phase II Study Utilizing Focal Radiation in Patients With 1-3 Brain Metastases Start of enrollment: 2003 Dec 01
Cerebrospinal Fluid Levels of Erlotinib in Patients Receiving Erlotinib For Stage III Non-Small Cell Lung Cancer Start of enrollment: 2004 Jan 01
Completed
Not Applicable
Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH) Start of enrollment: 2007 Dec 01
Active, not recruiting
Phase 3
Radiosurgery Plus Bevacizumab in Glioblastoma Start of enrollment: 2010 Feb 01
Terminated
Early Phase 1
A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma Start of enrollment: 2010 Jul 01
Completed
Phase 1
Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor Start of enrollment: 2012 Feb 01
Completed
Phase 1
Topotecan in Glioma Undergoing A Clinically-Indicated Surgical Resection Start of enrollment: 2015 Jul 06
Terminated
Early Phase 1
Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery in Patients With Grade III/ IV Glioma Start of enrollment: 2019 Jun 20
Terminated
Early Phase 1
Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for Gliomas Start of enrollment: 2019 Aug 15
Completed
A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511 Start of enrollment: 2011 Feb 01
Terminated
Phase 1
Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection Start of enrollment: 2021 Mar 02
Terminated
Phase 1
Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases Start of enrollment: 2021 Nov 30
Recruiting
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

1 citations
A Neuroradiologist's Guide to Operationalizing the Response Assessment in Neuro-Oncology (RANO) Criteria Version 2.0 for Gliomas in Adults.
Benjamin M Ellingson, Francesco Sanvito, Timothy F Cloughesy, Raymond Y Huang, Javier E Villanueva-Meyer
AJNR. American Journal of Neuroradiology. 2024-12-09
Development and validation of a clinical risk model for postoperative outcome in newly diagnosed glioblastoma: a report of the RANO resect group.
Philipp Karschnia, Jacob S Young, Gilbert C Youssef, Antonio Dono, Levin Häni
Neuro-Oncology. 2024-11-04
Multidisciplinary management strategies for recurrent brain metastasis after prior radiotherapy: An overview.
Rupesh Kotecha, Alonso La Rosa, Paul D Brown, Michael A Vogelbaum, Pierina Navarria
Neuro-Oncology. 2024-11-04

Journal Articles

PET Imaging in Patients with Meningioma—Report of the RANO/PET Group
Michael Vogelbaum, MD, Neuro-Oncology

Authored Content

First-in-Human Evaluation of the Cleveland Multiport Catheter for Convection-Enhanced Delivery of Topotecan in Recurrent High-Grade Glioma: Results of Pilot Trial 1 RelatedApril 2018
First-in-Human Evaluation of the Cleveland Multiport Catheter for Convection-Enhanced Delivery of Topotecan in Recurrent High-Grade Glioma: Results of Pilot Trial 1 RelatedApril 2018

Press Mentions

ORBEYE Exoscope Blue Light Imaging Mode Now Available for Use in NeurosurgeryAugust 26th, 2022
Glioblastoma: Are Phase 0 Trials a Window of Opportunity in Drug Development?July 21st, 2022
Phase 0 Clinical Trials: What You Need to KnowJuly 21st, 2022
Join now to see all

Professional Memberships

Congress of Neurological Surgeons - CNS
Member
American Association of Neurological Surgeons - AANS
Fellow
American College of Surgeons - ACS
Member

Insurance Accepted

Aetna Choice POS II
Aetna HMO
Anthem Blue Preferred HMO
BCBS Blue Card PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Great West PPO
Humana ChoiceCare Network PPO
Medical Mutual of Ohio SuperMed Plus
Medical Mutual of Ohio SuperMed POS
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment